DP2 antagonist and uses thereof

Details for Australian Patent Application No. 2011203649 (hide)

Owner Panmira Pharmaceuticals, LLC.

Inventors Brittain, Jason Edward; King, Christopher David; Stearns, Brian Andrew

Agent Spruson & Ferguson

Pub. Number AU-A-2011203649

PCT Pub. Number WO2011/085033

Priority 61/292,807 06.01.10 US

Filing date 5 January 2011

Wipo publication date 14 July 2011

International Classifications

C07C 323/59 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

A61K 31/10 (2006.01)

A61K 31/196 (2006.01)

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/085033 Priority application(s): WO2011/085033

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203651-Systems and methods for accessing content using an internet content guide

2011203647-Rotating continuous flow sub